Medicine & Health

The Brown School, the Institute for Public Health’s Center for Dissemination and Implementation and the School of Medicine’s Infectious Disease Division have launched the Infectious Disease Dissemination and Implementation Science (IDDI) Initiative.

Steven Lawrence, MD, an infectious disease specialist at the School of Medicine, and Cheri LeBlanc, MD, executive director of the Habif Health & Wellness Center on the Danforth Campus, explain how booster shots work, why the university is not requiring boosters at this time and the outlook for COVID on campus.

Warning labels on sugar-sweetened beverages and menu labeling requirements for chain restaurants could be a cost-effective policy leverage to prevent weight gain and reduce medical expenses, but their impact is expected to fade over time, finds a new study from the Brown School.

Research from the lab of Rajan Chakrabarty at the McKelvey School of Engineering connects environmental injustice to the spread of COVID-19 in communities with high minority populations.

A pediatric COVID-19 vaccine clinical trial is underway in St. Louis. Led by Washington University School of Medicine, about 140 area children will receive the two-shot Moderna vaccine or a placebo at St. Louis Children’s Hospital as part of a clinical trial involving about 100 medical institutions in the U.S. and Canada.

The National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health (NIH), has awarded $4.3 million to renew the Washington University Center for Diabetes Translation Research. 

Fred Ssewamala, the William E. Gordon Distinguished Professor at the Brown School, has received a grant to study the impact of a multilevel intervention to reduce HIV stigma and improve treatment outcomes among adolescents in Uganda.

A new round of recently awarded Global Incubator Seed Grants from the McDonnell International Scholars Academy will help kick-start more than a dozen high-impact, innovative projects taking place on five continents.

Researchers at Washington University School of Medicine and the University of Pittsburgh have discovered how Rift Valley fever virus enters cells, pointing the way to new therapies to treat the deadly disease.

A study by researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.